Atomoxetine-d3 HCl CAS 1217776-38-9
| CAS No. | 1217776-38-9 |
| Molecular Formula | - |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Atomoxetine-d3 HCl is closely related to deuterium isotope labeling, a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Atomoxetine-d3 HCl (CAS 1217776-38-9), a certified reference material (molecular formula C17H18D3NOHCl, MW 294.84 g/mol) for analytical method development and quality control.
The molecular framework of Atomoxetine-d3 HCl (C17H18D3NOHCl) is characterized by deuterium isotope labeling, a steroid core, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
CATO manufactures Atomoxetine-d3 HCl under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C17H18D3NO HCl |
| Molecular Weight | 294.84 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 8.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1990 |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Atomoxetine Standards
- Atomoxetine Impurity 50 (CAS 1007832-68-9)
- Atomoxetine impurity 40 (CAS 1010818-92-4)
- Atomoxetine impurity 41 (CAS 1010818-92-4（free base）)
- Atomoxetine EP Impurity C (CAS 1010818-96-8)
- Atomoxetine Impurity 9 HCl (CAS 1011-59-2)
- Atomoxetine EP impurity B (CAS 105314-53-2)
- Atomoxetine impurity 01 (CAS 109306-10-7)
- Atomoxetine EP Impurity H (S-Isomer) (CAS 114133-37-8)
Recommended Standards
- 3-Hydroxy-2,2,3-trimethylbutanoic acid (CAS 594-88-7)
- (2-(2-Bromopyridin-3-yl)piperidin-1-yl)(phenyl)methanone (CAS 1352500-13-0)
- (6-(Furan-2-yl)pyridin-3-yl)boronic acid (CAS 2225177-92-2)
- 4-(1',3'-dimethyl-1H,1'H-3,4'-bipyrazol-1-yl)aniline (CAS 1006348-74-8)
- 3-Bromo-7-(trifluoromethyl)quinolin-4-ol (CAS 65673-94-1)
- 4-Bromo-N-morpholinobenzenesulfonamide (CAS 64268-87-7)
- 5-fluoro-1-N-propylbenzene-1,2-diamine (CAS 1072928-93-8)
- 2-((tert-Butoxycarbonyl)amino)-3-(3-phenoxyphenyl)propanoic acid (CAS 119349-24-5)
- N-(2-Methoxyphenyl)-3-(4-methoxyphenyl)-2-(2H-1,2,3,4-tetrazol-5-yl)propanamide (CAS 483993-14-2)
- D-[Arg]30-Semaglutide (CAS CATO-C4X-222653)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com